Latest Insider Transactions at Protagonist Therapeutics, Inc (PTGX)
This section provides a real-time view of insider transactions for Protagonist Therapeutics, Inc (PTGX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Protagonist Therapeutics, Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Protagonist Therapeutics, Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 20
2018
|
Canaan X L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
17,060
-0.71%
|
$341,200
$20.61 P/Share
|
|
Mar 19
2018
|
Canaan X L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
13,439
-0.55%
|
$268,780
$20.57 P/Share
|
|
Mar 16
2018
|
Canaan X L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
6,926
-0.28%
|
$138,520
$20.51 P/Share
|
|
Mar 15
2018
|
Canaan X L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
11,751
-0.48%
|
$235,020
$20.64 P/Share
|
|
Mar 14
2018
|
Canaan X L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
200
-0.01%
|
$4,000
$20.77 P/Share
|
|
Mar 13
2018
|
Canaan X L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,204
-0.05%
|
$24,080
$20.84 P/Share
|
|
Aug 16
2016
|
Johnson & Johnson > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
583,333
+19.24%
|
$6,999,996
$12.0 P/Share
|
|
Aug 16
2016
|
Johnson & Johnson > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,865,850
+41.27%
|
-
|